Default object view. Click to create a custom template, Node ID: 130108, Object ID: 76576

Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomiz...

Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial

No relation

Yes

No relation

No

08/12/2015 5:29 pm

No